Analysis of the Distribution of Total Phosphine and the Characteristics of Phosphine Poisoning in 29 Victims / 法医学杂志

OBJECTIVES@#To study the distribution of total phosphine in phosphine poisoning victims and summarize the characteristics of phosphine poisoning cases.@*METHODS@#The phosphine and its metabolites in the biological samples of 29 victims in 16 phosphine poisoning cases were qualified and quantified by headspace gas chromatography-mass spectrometry.@*RESULTS@#Five victims among 29 were poisoned by ingestion of aluminium phosphide and 24 by inhalation of phosphine gas. Phosphine metabolites were detected in the biological samples of 23 victims, and the concentrations of total phosphine in blood ranged 0.5-34.0 μg/mL. The total concentration of phosphine in liver tissue was up to 71.0 μg/g. Phosphine was not detected in the blood of the other six survived victims, which may be related to the small amount of phosphine exposure and the delay in blood sampling.@*CONCLUSIONS@#The total concentration of phosphine in blood and tissues caused by aluminum phosphine ingestion is higher than that caused by phosphine gas inhalation. The death cases of phosphine inhalation are characterized by long exposure time, repeated exposures and age susceptibility.

Aluminum phosphate shows more adjuvanticity than Aluminum hydroxide in recombinant hepatitis-B vaccine formulation

Although a number of investigation have been carried out to find alternative adjuvants to aluminum salts in vaccine formulations, they are still extensively used due to their good track record of safety, low cost and proper adjuvanticity with a variety of antigens. Adsorption of antigens onto aluminum compounds depends heavily on electrostatic forces between adjuvant and antigen. Commercial recombinant protein hepatitis B vaccines containing aluminum hydroxide as adjuvant is facing low induction of immunity in some sections of the vaccinated population. To follow the current global efforts in finding more potent hepatitis B vaccine formulation, adjuvanticity of aluminum phosphate has been compared to aluminum hydroxide. The adjuvant properties of aluminum hydroxide and aluminum phosphate in a vaccine formulation containing a locally manufactured hepatitis B [HBs] surface antigen was evaluated in Balb/C mice. The formulations were administered intra peritoneally [i.p.] and the titers of antibody which was induced after 28 days were determined using ELISA technique. The geometric mean of antibody titer [GMT], seroconversion and seroprotection rates, ED50 and relative potency of different formulations were determined. All the adjuvanicity markers obtained in aluminum phosphate formulation were significantly higher than aluminum hydroxide. The geometric mean of antibody titer of aluminum phosphate was approximately three folds more than aluminum hydroxide. Aluminum phosphate showed more adjuvanticity than aluminum hydroxide in hepatitis B vaccine. Therefore the use of aluminum phosphate as adjuvant in this vaccine may lead to higher immunity with longer duration of effects in vaccinated groups

Conductometric study of AlCl3 in anhydrous formic and acetic acids

The ionic dissociation constant and limiting molar conductance of A1C1[3] have been determined by conductometric measurements in both anhydrous formic and acetic acids. The conductometric data were analyzed according to Onsager Sheldovsky and Kraus-Bray methods at different concentrations ranging from 3.71 x 10[-3] to 1.7 x 10[-3] mol dm [-3] at different temperatures [namely 30, 35 and 40 degree]. The dissociation constants of AlCL[3] in anhydrous formic acid are larger than those obtained in anhydrous acetic acid. The dissociation constant in case of anhydrous formic acid increases with temperature but decreases in case of anhydrous acetic acid. This has been interpreted based on the dielectric constant of both formic and acetic acid solutions in non-aqueous media